论文部分内容阅读
在免疫功能抑制的患者中,系统性真菌感染治疗有一定难度,致死率较高。近来有毒副作用小、抗菌性强的脂质体两性霉素B、伏力康唑和卡斯波菌素等新抗真菌药问世,有效改善了系统性真菌感染的治疗和预后。
In immunosuppressed patients, systemic fungal infection has a certain degree of difficulty, higher mortality. Recent toxic side effects, strong antibacterial liposome amphotericin B, voriconazole and Kaspersporin and other new antifungal drugs come out, effectively improve the treatment and prognosis of systemic fungal infections.